Experiment 824225
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | ANTMAN,K: POMFRET,E: KARP,G: SKARIN,A: CANELLOS,G:. (1984). PHASE II TRIAL OF ETOPOSIDE IN PREVIOUSLY TREATED SMALL CELL CARCINOMA OF THE LUNG.. 68(11) |
| Amount utilized | |
| Compound isolated | |
| Disease | 23 PATIENTS WITH SMALL CELL LUNG CARCINOMA WERE GIVEN DRUG ON DAYS 1,3 AND 5 EVERY 3 WEEKS. 15 PATIENTS SHOWED MODERATE TO SEVERE HEMATOLOGIC TOXIC EFFECTS. 1 PATIENT EXHIBITED A WBC COUNT LESS THAN 1000 AND IN 2 PATIENTS PLATLETS FELL BELOW 25000 FEW RESPONSES WERE OBSERVED USING A WEEKLY DOSE SCHEDULE IV. ORAL DOSING 3 TO 5 DAYS WEEKLY EVERY 3 WEEKS APPEARED SUPERIOR TO WEEKLY IV DOSING. |
| Dose amount | 0.125 GM |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |